Collalysin

Collalysin: an effective pharmacological agent for the treatment of purulent-necrotic processes

In the world of pharmacology, there are many drugs designed to combat various diseases and conditions of the body. One of these drugs developed and produced in Russia is Collalysin. This is an enzymatic agent used in purulent-necrotic processes, and it deserves special attention.

Collalysin is produced by Biopreparat (Russia), the St. Petersburg Research Institute of Vaccines and Serums, as well as an enterprise for the production of bacterial preparations (Russia). This indicates a high level of development and production of the drug in Russia.

The drug is available in several dosage forms: lyophilized powder with varying concentrations of the active substance and lyophilisate for the preparation of a solution for injection and topical use. This provides flexibility and ease of use of the drug, allowing you to choose the optimal form for each specific case.

The main component of Collalysin is an enzyme preparation obtained from the pancreas of slaughter cattle. This is a natural substance that is highly effective in the fight against purulent-necrotic processes.

Collalysin is widely used in medicine for the prevention and treatment of various diseases and conditions. It is effective for symblepharon, cicatricial changes in the skin of the eyelids and conjunctiva of the eyeball after a burn, for strictures of the lacrimal ducts, corneal opacities, plastic iridocyclitis, secondary cataracts, vitreous opacities, retinal scars, for traumatic hemorrhage in the vitreous, and also as a treatment cicatricial skin changes.

Like any medicine, Collalysin has contraindications and possible side effects. The drug is not recommended for use in cases of incomplete epithelization of the cornea after a burn, combination of symblepharon with a corneal ulcer, presence of defects in the sclera, hemorrhage into the vitreous less than 0.5 of its volume, signs of blood coagulation in the vitreous or a pronounced reaction after administration of 1KE. Possible side effects are the development of corneal ulcers and allergic reactions.

It is important to note that the use of Collalysin should be under supervision and as prescribed by a physician. The dosage and regimen of use are determined individually depending on the specific case and severity of the disease.

Collalysin is an effective pharmacological agent for the treatment of purulent-necrotic processes. It helps restore damaged tissue, promotes the healing of wounds and scars, and also improves the general condition of the patient. However, before using the drug, you should consult your doctor to evaluate the indications, contraindications and possible risks.

It is also important to note that the information provided above is based on my knowledge prior to September 2021. Therefore, it is recommended that you consult current sources and consult with a medical professional to obtain accurate and up-to-date information about Collalysin or any other medicine.